Show simple item record

dc.contributor.authorOstojic, Sergej M.
dc.date.accessioned2022-07-19T12:17:35Z
dc.date.available2022-07-19T12:17:35Z
dc.date.created2022-06-24T10:21:06Z
dc.date.issued2022
dc.identifier.citationOstojic, S.M. (2022). Guanidinoacetic Acid as a Nutritional Adjuvant to Multiple Sclerosis Therapy. Frontiers in Human Neuroscience, 16, 5.en_US
dc.identifier.issn1662-5161
dc.identifier.urihttps://hdl.handle.net/11250/3006589
dc.language.isoengen_US
dc.publisherFrontiers Media S.A.en_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleGuanidinoacetic Acid as a Nutritional Adjuvant to Multiple Sclerosis Therapyen_US
dc.title.alternativeGuanidinoacetic Acid as a Nutritional Adjuvant to Multiple Sclerosis Therapyen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2022 The Author(s)en_US
dc.subject.nsiVDP::Medisinske Fag: 700::Helsefag: 800en_US
dc.source.pagenumber5en_US
dc.source.volume16en_US
dc.source.journalFrontiers in Human Neuroscienceen_US
dc.identifier.doihttps://doi.org/10.3389/fnhum.2022.871535
dc.identifier.cristin2034742
dc.source.articlenumber871535en_US
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal